No Brand Name for You: AMP Adds New Layer to Its Theranostics Position

In a new position statement released today, the molecular pathology group said it hopes to encourage drug makers to identify reference tests in their labels "based on their molecular description" and not by their brand name.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.